Sarcomeric gene mutations in sudden infant death syndrome (SIDS)

Area of Science:

• Cardiology
• Genetics
• Pediatrics

Background:

• Sudden infant death syndrome (SIDS) is the leading cause of death in infants aged 1-12 months in developed countries.
• While channelopathies are known causes of SIDS, the role of other sudden cardiac death-associated diseases like hypertrophic cardiomyopathy (HCM) remains unclear.
• Genetic mutations in sarcomeric proteins can impair myocyte contraction, leading to hypertrophy and disarray, but the arrhythmogenic risk in early, phenotypically absent forms is unknown.

Purpose of the Study:

• To investigate whether genetic defects in sarcomeric proteins associated with HCM could be responsible for SIDS.
• To determine if mutations causing HCM can lead to sudden cardiac death in infants without identifiable cardiac phenotypes.

Main Methods:

• Analysis of 286 SIDS cases for common genes implicated in adult HCM.
• Screening of 680 mutations across 16 genes using Sequenom MassARRAY(®) System (MALDI-TOF MS).
• Conventional sequencing for novel mutation detection.

Main Results:

• Ten SIDS cases with normal hearts exhibited mutated alleles in nine genetic variants associated with HCM.
• One novel mutation was identified through conventional sequencing.
• Genetic mutations linked to HCM can cause sudden cardiac death without a discernible phenotype.

Conclusions:

• Genetic mutations associated with HCM may be an underlying cause of SIDS.
• The study highlights the potential for subclinical genetic cardiac conditions to result in unexplained infant death.
• Further research into genetic screening for HCM-associated variants in SIDS cases is warranted.